Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $51.02 $63.08 Friday, 10th May 2024 CRSP stock ended at $51.17. This is 4.44% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 7.59% from a day low at $51.02 to a day high of $54.89.
90 days $51.02 $91.10
52 weeks $37.55 $91.10

Historical CRISPR Therapeutics AG prices

Date Open High Low Close Volume
Jan 24, 2024 $66.98 $67.33 $62.88 $63.01 1 952 761
Jan 23, 2024 $66.23 $66.66 $64.32 $66.19 1 618 310
Jan 22, 2024 $62.52 $65.80 $62.21 $65.26 2 379 496
Jan 19, 2024 $61.00 $61.99 $60.14 $61.99 2 090 552
Jan 18, 2024 $61.10 $61.23 $59.70 $60.98 1 400 290
Jan 17, 2024 $62.25 $63.10 $60.25 $60.86 2 268 636
Jan 16, 2024 $63.21 $63.58 $62.02 $63.43 1 715 475
Jan 12, 2024 $65.15 $67.07 $63.60 $64.25 2 096 215
Jan 11, 2024 $62.07 $65.86 $61.96 $64.84 3 602 947
Jan 10, 2024 $62.57 $63.34 $60.61 $63.34 1 785 538
Jan 09, 2024 $61.55 $63.71 $60.75 $62.63 1 580 019
Jan 08, 2024 $60.55 $62.80 $58.29 $62.69 2 050 714
Jan 05, 2024 $60.91 $61.41 $59.35 $60.67 2 033 595
Jan 04, 2024 $62.42 $63.42 $61.83 $61.94 1 450 098
Jan 03, 2024 $64.58 $65.27 $62.16 $62.56 1 986 339
Jan 02, 2024 $61.84 $68.48 $61.51 $66.06 3 621 264
Dec 29, 2023 $64.16 $64.59 $62.58 $62.60 1 859 223
Dec 28, 2023 $65.45 $65.76 $63.41 $64.30 1 792 333
Dec 27, 2023 $66.40 $67.16 $63.80 $64.96 1 589 206
Dec 26, 2023 $64.83 $65.89 $64.03 $65.33 1 712 202
Dec 22, 2023 $61.01 $64.78 $60.75 $63.67 2 832 929
Dec 21, 2023 $61.65 $62.64 $59.29 $60.60 2 531 293
Dec 20, 2023 $66.43 $66.43 $60.74 $60.81 3 729 349
Dec 19, 2023 $61.59 $67.46 $61.59 $66.83 3 153 117
Dec 18, 2023 $62.54 $63.58 $61.27 $61.40 1 623 161
Click to get the best stock tips daily for free!

About CRISPR Therapeutics AG

CRISPR Therapeutics CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA. The company has a portfolio of therapeutic programs across a range of disease areas, including hemoglo... CRSP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT